ADC Therapeutics SA Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -0.12M-0.12M-0.25M-0.27M-0.15M
Depreciation and Depletion 0.49M0.55M0.77M0.92M1.06M1.19M1.33M
Share-based Compensation 0.47M1.12M37.59M60.48M49.32M13.49M6.57M
Deferred Taxes -0.03M-1.62M37.10M
Gains from Sales and Divestitures 0.00M0.00M0.00M
Gains from Investment Securities -0.00M-0.00M-0.00M-0.00M-11.50M-0.50M1.16M
Asset Writedowns and Impairment 2.17M1.61M1.52M
Cash from Operations -122.23M-122.44M-168.73M-233.38M-138.31M-118.69M-123.83M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.05M0.13M12.20M19.21M28.22M
Amortization of Deferred Charges 2.50M3.02M0.90M
Depreciation & Amortization (CF) 0.25M0.03M0.26M0.13M0.34M1.19M1.33M
Change in Working Capital
Change in Receivables 0.90M0.19M-30.22M42.75M-47.79M-4.77M
Change in Inventory -3.02M9.65M5.71M3.73M
Change in Account Payables -0.86M-3.42M1.92M6.80M0.31M3.17M2.46M
Change in Accured Expenses 16.25M-14.14M11.14M
Change in Taxes 0.22M0.58M0.33M4.57M1.85M
Other Working Capital Changes -0.97M-3.84M-4.50M-6.36M11.46M7.39M-6.92M
Investing Activities
Capital Expenditures 0.94M0.36M0.80M3.43M0.69M3.22M0.87M
Change in Intangibles -0.00M-0.00M-0.00M-0.00M-0.00M
Cash from Investing Activities -2.51M-2.25M-2.83M-6.67M-0.69M-3.22M-0.87M
Financing Activities
Other financing activities 0.00M2.78M
Cash from Financing Activities -0.02M100.51M494.97M267.39M-0.90M73.88M97.05M
Debt Issuance and Repayment
Net Debt Issuances and Repayments 0.00M0.00M0.01M0.00M
Additional items
Exchange Rate Effect -0.05M0.06M0.23M0.01M-0.21M0.18M-0.08M
Change in Cash -123.89M-23.32M323.41M27.34M-139.90M-48.03M-27.65M
Free Cash Flow -123.17M-122.80M-169.53M-236.81M-139.00M-121.90M-124.70M
Net Cash Flow -124.76M-24.18M323.41M27.34M-139.90M-48.03M-27.65M